A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

Background Controlling the spread of SARS-CoV-2 is problematic because of transmission driven by asymptomatic and pre-symptomatic individuals. Community screening can help identify these individuals but is often too expensive for countries with limited health care resources. Low-cost ELISA assays ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Humbert, Maria Victoria, Opurum, Precious Chinonyerem, Brendish, Nathan J, Poole, Stephen, He, Peijun, Katis, Ioannis, Quaye, Jerry, Bediako, Yaw, Duriez, Patrick Jacques, Eason, Robert W, Sones, Collin, Quaye, Osbourne, Awandare, Gordon A, Christodoulides, Myron, Clark, Tristan W, Quashie, Peter K, McCormick, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485707/
https://www.ncbi.nlm.nih.gov/pubmed/34606784
http://dx.doi.org/10.1016/j.jinf.2021.08.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485707/
https://www.ncbi.nlm.nih.gov/pubmed/34606784
http://dx.doi.org/10.1016/j.jinf.2021.08.049

Ejemplares similares